Literature DB >> 34256842

Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo.

Yong-Hong Wang1,2, Ya-Chao Tao1,2, Dong-Bo Wu1,2, Meng-Lan Wang1,2, Hong Tang3,4, En-Qiang Chen5,6.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) have to be expanded in vitro to reach a sufficient cell dose for the treatment of various diseases. During the process of expansion, some obstacles remain to be overcome. The purpose of this study was to investigate the effects of storage solutions and heterogeneity on the behavior of MSCs in vitro and in vivo.
METHODS: Umbilical cord MSCs (UC-MSCs) of similar sizes within normal ranges were suspended in three different storage solutions, phosphate buffer solution, normal saline, and Dulbecco's modified Eagle medium. Then, the ultrastructure, viability, and safety of these cells were compared. Other two UC-MSC populations of different sizes were categorized based on their mean diameters. The ultrastructure, proliferation, immunosuppression, hepatic differentiation potential, and number of senescent cells were investigated and compared. The survival rates of mice after the infusion of UC-MSCs of different sizes were compared.
RESULTS: For UC-MSCs suspended in different storage solutions, the cell apoptosis rates, ultrastructure, and survival rates of mice were similar, and no differences were observed. Cells with a diameter of 19.14 ± 4.89 μm were categorized as the larger UC-MSC population, and cells with a diameter of 15.58 ± 3.81 μm were categorized as the smaller population. The mean diameter of the larger UC-MSC population was significantly larger than that of the smaller UC-MSC population (p < 0.01). Smaller UC-MSCs had more powerful proliferation and immunosuppressive potential and a higher nucleus-cytoplasm ratio than those of large UC-MSCs. The number of cells positive for β-galactosidase staining was higher in the larger UC-MSC population than in the smaller UC-MSC population. The survival rates of mice receiving 1 × 106 or 2 × 106 smaller UC-MSCs were 100%, both of which were higher than those of mice receiving the same amounts of larger UC-MSCs (p < 0.01). The cause of mouse death was explored and it was found that some larger UC-MSCs accumulated in the pulmonary capillary in dead mice.
CONCLUSION: Different storage solutions showed no significant effects on cell behavior, whereas heterogeneity was quite prevalent in MSC populations and might limit cells application. Hence, it is necessary to establish a more precise standardization for culture-expanded MSCs.
© 2021. The Author(s).

Entities:  

Keywords:  Function; Heterogeneity; Mesenchymal stem cells; Morphology; Storage solution

Year:  2021        PMID: 34256842     DOI: 10.1186/s13287-021-02450-2

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  33 in total

1.  Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

Authors:  Julián Panés; Damián García-Olmo; Gert Van Assche; Jean Frederic Colombel; Walter Reinisch; Daniel C Baumgart; Axel Dignass; Maria Nachury; Marc Ferrante; Lili Kazemi-Shirazi; Jean C Grimaud; Fernando de la Portilla; Eran Goldin; Marie Paule Richard; Anne Leselbaum; Silvio Danese
Journal:  Lancet       Date:  2016-07-29       Impact factor: 79.321

Review 2.  Isolation, cultivation, and characterization of human mesenchymal stem cells.

Authors:  Dolly Mushahary; Andreas Spittler; Cornelia Kasper; Viktoria Weber; Verena Charwat
Journal:  Cytometry A       Date:  2017-10-26       Impact factor: 4.355

3.  Intra-articular Mesenchymal Stem Cell Therapy for the Human Joint: A Systematic Review.

Authors:  James A McIntyre; Ian A Jones; Bo Han; C Thomas Vangsness
Journal:  Am J Sports Med       Date:  2017-11-03       Impact factor: 6.202

Review 4.  Assessment of Consistency in Assignment of Severe (Grade 3) Squamous Metaplasia to Human Bulbar Conjunctiva Impression Cytology Cell Samples.

Authors:  Michael J Doughty
Journal:  Ocul Surf       Date:  2015-07-09       Impact factor: 5.033

5.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

6.  An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells.

Authors:  Alessandro Bertolo; Marco Mehr; Tiziana Janner-Jametti; Ursula Graumann; Niklaus Aebli; Martin Baur; Stephen J Ferguson; Jivko V Stoyanov
Journal:  J Tissue Eng Regen Med       Date:  2013-04-10       Impact factor: 3.963

7.  Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro.

Authors:  Bo Liu; Fengxia Ding; Dong Hu; Yu Zhou; Chunlan Long; Lianju Shen; Yuanyuan Zhang; Deying Zhang; Guanghui Wei
Journal:  Stem Cell Res Ther       Date:  2018-01-12       Impact factor: 6.832

8.  CXCL12 overexpression promotes the angiogenesis potential of periodontal ligament stem cells.

Authors:  Lei Zhang; Yong Zhou; Xiaoyu Sun; Jian Zhou; Pishan Yang
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

9.  Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro.

Authors:  Yueh-Hsun Kevin Yang; Courtney R Ogando; Carmine Wang See; Tsui-Yun Chang; Gilda A Barabino
Journal:  Stem Cell Res Ther       Date:  2018-05-11       Impact factor: 6.832

10.  Functional Profiling of Chondrogenically Induced Multipotent Stromal Cell Aggregates Reveals Transcriptomic and Emergent Morphological Phenotypes Predictive of Differentiation Capacity.

Authors:  Johnny Lam; Ian H Bellayr; Ross A Marklein; Steven R Bauer; Raj K Puri; Kyung E Sung
Journal:  Stem Cells Transl Med       Date:  2018-08-07       Impact factor: 6.940

View more
  2 in total

1.  Insight into generation of induced mesenchymal stem cells from induced pluripotent cells.

Authors:  Mahmood S Choudhery; Ruhma Mahmood
Journal:  World J Stem Cells       Date:  2022-01-26       Impact factor: 5.326

Review 2.  Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside.

Authors:  Zhou Zou; Xiaohe Luo; Zhengkun Chen; Yu Shrike Zhang; Chunyi Wen
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.